Bryostatin Induces Protein Kinase C Modulation, Mcl-1 Up-Regulation and Phosphorylation of Bcl-2 Resulting in Cellular Differentiation and Resistance to Drug-induced Apoptosis in B-cell Chronic Lymphocytic Leukemia Cells

References

• Hanada, M., Delia, D., Aiello, A., Stadmauer, E. and Reed, J.C. (1993) "bc1-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia", Blood, 82, 1820— 1828.
   Google Scholar
• Pepper, C., Hoy, T. and Bentley, P. (1997) "Bc1-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance", Br. J. Cancer, 76, 935–938.
   Web of Science ®Google Scholar
• Aguilar-Santelises, M., Rottenberg, M.E., Lewin, N., Mellstedt, H. and Jondal, M. (1996) "Bc1-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression", Int. J. Cancer, 69, 114 — 119.
   Web of Science ®Google Scholar
• Kitada, S., Andersen, J., Akar, S., Zapata, J.M., Takayama, S., Krajewski, S., Wang, H-G., Zhang, X., Bullrich, F., Croce, M.C., Rai, K., Hines, J. and Reed, J.C. (1998) "Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses", Blood, 91, 3379 — 3389.
   Google Scholar
• Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P.R., Poustka, A., Hunstein, W. and Lichter, P. (1995) "p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias", Blood, 85, 1580 — 1589.
   Google Scholar
• Plunkett, W., Begleiter, A., Liliemark, J.0. and Reed, J.C. (1996) "Why do drugs work in CLL?", Leuk. Lymphoma, 22\(Suppl 2), 1 — 11.
   PubMed Web of Science ®Google Scholar
• Jarvis, W.D. and Grant, S. (1999) "Protein kinase C targeting in antineoplastic treatment strategies", Invest. New Drugs, 17, 227 — 240.
   Web of Science ®Google Scholar
• Deacon, E.M., Pongracz, J., Griffiths, G. and Lord, J.M. (1997) "Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis", Mol. Pathol., 50, 124 — 131.
   Web of Science ®Google Scholar
• Kaubisch, A. and Schwartz, G.K. (2000) "Cyclin-dependent kinase and protein kinase C inhibitors: A novel class of antineoplastic agents in clinical development", Cancer J., 6, 192–212.
   PubMed Web of Science ®Google Scholar
• Goekjian, P.G. and Jirousek, M.R. (1999) "Protein kinase C in the treatment of disease: Signal transduction pathways, inhibitors and agents in development", Curr. Med. Chem., 6, 877–903.
   Web of Science ®Google Scholar
• Szallasi, Z., Smith, C.B., Pettit, G.R. and Blumberg, P.M. (1994) "Differential regulation of protein kinase C isoenzymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts", J Biol Chem., 269, 2118–2124.
   PubMed Web of Science ®Google Scholar
• Lee, H.W., Smith, L., Pettit, G.R., Vinitsky, A. and Smith, J.B. (1996) "Ubiquitination of protein kinase C-alpha and degradation by the proteasome", J. Biol. Chem., 271, 20973–20976.
   Web of Science ®Google Scholar
• Mutter, R. and Wills, M. (2000) "Chemistry and biology of the Bryostatins", Bioorg. Med. Chem., 8, 1841–1860.
   Web of Science ®Google Scholar
• Maki, A., Diwakaran, H., Redman, B., Al-Asfar, S., Petit, G.R., Mohammad, R.M. and Al-Katib, A. (1995) "The bc1-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma", AntiCancer Drugs, 6, 392 — 397.
   Google Scholar
• May, W.S., Tyler, P.G., Ito, T., Armstrong, D.K., Qatsha, K.A. and Davidson, N.E. (1994) "Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppres-sion of apoptosis"„ J. Biol. Chem., 269, 26865–26870.
   Web of Science ®Google Scholar
• Tan, Y., Ruan, H., Demeter, M.R. and Comb, M.J. (1999) "p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway", J. Biol. Chem., 274, 34859–34867.
   Web of Science ®Google Scholar
• Ruvolo, P.P., Deng, X., Carr, B.K. and May, W.S. (1998) "A functional role for mitochondrial protein kinase C alpha in Bc1-2 phosphorylation and suppression of apoptosis", J. Biol. Chem., 273, 25436— 25442.
   Web of Science ®Google Scholar
• Lin, H., Chen, C., Li, X. and Chen, B.D. (2002) "Activation of the MEK/MAPK pathway is involved in Bryostatin 1-induced mono-cytic differentiation and up-regulation of X-linked inhibitor of apoptosis protein", Exp. Cell. Res., 272, 192–198.
   Web of Science ®Google Scholar
• Wall, N.R., Mohammad, R.M. and Al-Katib, A.M. (2001) "Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh", Cell Growth Differ., 12, 641–647.
   PubMedGoogle Scholar
• Al-Katib, A., Mohammad, R.M., Dan, M., Hussein, M.E., Akhtar, A., Pettit, G.R., et al. (1993) "Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro", Exp. Hematol., 21, 61 — 65.
   Web of Science ®Google Scholar
• Mohammad, R.M., Beck, F.W.J., Katato, K., Hamdy, N., Wall, N. and Al-Katib, A. (1998) "Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5, -NT and Bax/Bc1-2", Biol. Chem., 379, 1253–1261.
   Google Scholar
• Kitada, S., Zapata, J.M., Andreeff, M. and Reed, J.C. (1999) "Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lympho-cytic leukaemia", Br. J. Haematol., 106, 995–1004.
   Web of Science ®Google Scholar
• Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., et al. (1981) "A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis", Cancer, 48, 198 — 206.
   Google Scholar
• Ferlini, C., Di Cesare, S., Rainaldi, G., Malorni, W., Samoggia, P., Biselli, R., etal. (1996) "Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques", Cytometry, 24, 106 — 115.
   Google Scholar
• Pepper, C., Thomas, A., Hoy, T. and Bentley, P. (1999) "Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones", Br. J. Haematol., 104, 581 —588.
   Web of Science ®Google Scholar
• Vermes, I., Haanen, C., Steffens-Nakken, R. and Reutelingsperger, C. (1995) "A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V", J. Immunol. Methods, 184, 39 — 51.
   PubMed Web of Science ®Google Scholar
• Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., et al. (1991) "The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protien kinase C", J. Biol. Chem., 266, 15771 — 15781.
   Google Scholar
• Vlahos, CJ., Matter, W.F., Hui, K.Y. and Brown, R.F. (1994) "A specific inhibitor of phosphatidylinosito1-3-kinase, 2-(4-morpholi-ny1)-8-pheny1-4H-1-benzopyran-4-one (LY294002)", J. BioL Chem., 269, 5241–5248.
   PubMed Web of Science ®Google Scholar
• Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J. and Saltiel, AR. (1995) "A synthetic inhibitor of the mitogen-activated protein kinase cascade", Proc. Natl. Acad. Sci. USA, 92, 7686–7689.
   PubMed Web of Science ®Google Scholar
• Mohammad, R.M., Katato, K., Almatchy, V.P., Wall, N., Liu, K-Z., Schultz, C.P., et al. (1998) "Sequential treatment of human chronic lymphocytic leukemia with Bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies", Clin. Cancer Res., 4, 445 —453.
   Google Scholar
• Martiny-Baron, G., Kazanietz, M.G., Mischak, H., Blumberg, P.M., Kochs, G., Hug, H., et al. (1993) "Selective inhibition of protein kinase C isoenzymes by the indolocarbazole Go 6976", J. BioL Chem., 268, 9194 — 9197.
   PubMed Web of Science ®Google Scholar
• Nishizuka, Y. (1988) "The molecular heterogeneity of protein kinase C and its implications for cellular regulation", Nature, 334, 661 —665.
   Google Scholar
• Gartenhaus, R., Hoffman, M., Fuchs, A., Billet, H., Wang, P., Gentile, P., etal. (1996) "Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro", Leuk. Lymphoma, 22, 97 — 101.
   Google Scholar
• Beck, F.W., Al-Katib, AM., Ahmad, I., Wall, N.R., Liu, K-Z., Mantsch, H.H., et al. (2000) "Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells", Int. J. Mol. Med., 5, 341–347.
   PubMed Web of Science ®Google Scholar
• Drexler, HG., Quentmeier, H., Dirks, W.G., Uphoff, C.C. and Macleod, R.A. (2002) "DNA profiling and cytogenetic analysis of cell line WSU-CLL reveal cross-contamination with cell line REH (pre B-ALL)", Leukemia, 16, 1868–1870.
   Web of Science ®Google Scholar
• Varterasian, ML., Mohammad, R.M., Shurafa, M., Hulburd, K., Pemberton, P.A., Rodriguez, D.H., et al. (2000) "Phase II trial of Bryostatin 1 in patients with relapsed low-grade non-Hodkin's lymphoma and chronic lymphocytic leukemia", Clin. Cancer Res., 6, 825–828.
   Web of Science ®Google Scholar
• Barragán, M., Bellosillo, B., Campas, C., Colomer, D., Pons, G. and Gil, J. (2002) "Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells", Blood, 99, 2969 — 2976.
   Google Scholar
• Wickremasinghe, R.H., Ganeshaguru, K., Jones, D.T., Lindsay, C., Spanswick, Vi., Hartley, JA., et al. (2001) "Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lym-phocytic leukaemia cells", Br. J. Haematol., 114, 608–615.
   Web of Science ®Google Scholar
• Pepper, C., Hoy, T. and Bentley, P. (1998) "Elevated Bc1-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic leukaemia and are correlated with in vivo chemoresistance", Leuk. Lymphoma, 28, 355–361.
   PubMed Web of Science ®Google Scholar
• Bannerji, R., Kitada, S., Flinn, I.W., Pearson, M., Young, D., Reed, J.C., et al. (2003) "Apoptotic-regulatory and complement-protect-ing protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance", J. Clin. °flea, 21, 1466–1471.
   Google Scholar
• Arita, Y., Santiago-Swarz, F. and Coppock, D.L. (2000) "Survival mechanisms induced by 12-0-tetradecanoylphorbol-13-acetate in normal human melanocytes include inhibition of apoptosis and increased Bc1-2 expression", Melanoma Res., 10, 412–420.
   PubMed Web of Science ®Google Scholar
• Lombet, A., Zujovic, V., Kandouz, M., Billardon, C., Carvajal-Gonzalez, S., Gompel, A., et al. (2001) "Resistance to induced apoptosis in the human neuroblastoma cell line SK-N-SH in relation to neuronal differentiation. Role of Bc1-2 protein family", Eur. J. Biochem., 268, 1352— 1362.
   Google Scholar
• Gubina, E., Rinaudo, M.S., Szallasi, Z., Blumberg, P.M. and Mufson, R.A. (1998) "Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bc1-2 expression", Blood, 91, 823 — 829.
   Google Scholar
• Ruvolo, P.P., Deng, X. and May, W.S. (2001) "Phosphorylation of Bc1-2 and regulation of apoptosis", Leukemia, 15, 515— 522.
   Google Scholar
• Blagosklonny, MV., Giannakakou, P., el-Deiry, W.S., Kingston, D.G., Higgs, P.I., Neckers, L., et al. (1997) "Raf-1/bc1-2 phosphor-ylation: a step from microtubule damage to cell death", Cancer Res., 57, 130–135.
   PubMed Web of Science ®Google Scholar
• Lomo, J., Smeland, E.B., Krajewski, S., Reed, J.C. and Blomhoff, HK. (1996) "Expression of the Bc1-2 homologue Mc-1 correlates with survival of peripheral blood B lymphocytes", Cancer Res., 56, 40–43.
   PubMed Web of Science ®Google Scholar
• Craig, R.W. (2002) "MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigen-esis", Leukemia, 16, 444–454.
   PubMed Web of Science ®Google Scholar